Regulation of neutrophil apoptosis by sodium butyrate

Biologicals

Volumn 24, Issue 4, 1996, Pages 301-306

  Moulding, Dale ^a   Quayle, Julie A ^a   Stringer, Rebecca E ^a   Hart, C Anthony ^a   Edwards, Steven W ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CD16 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

APOPTOSIS; ARTICLE; CELL STRUCTURE; HALF LIFE TIME; HUMAN; HUMAN CELL; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; RESPIRATORY BURST;

EID: 0030424008     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1006/biol.1996.0041     Document Type: Article

References (32)

1. 1. Haslett C. Resoution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes. Clin Sci 1992; 83: 639-648.
2. 2. Edwards SW. Biochemistry and Physiology of the Neutrophil. New York, NY, Cambridge University Press (1994).
3. 3. Bodey GP. Infections in cancer patients. Cancer Treat Rev 1975; 2: 89-126.
4. 4. Bodey GP, Buckley M, Sathe YS et al. Quantitative relationships between circulating leukocytes and infections in patients with acute leukemias. Ann Int Med 1966; 62: 328-334.
5. 5. Brach MA, deVos S, Gruss H-J et al. Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood 1992; 80: 2920-2924.
6. 6. Collota F, Re F, Polentarutti N et al. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992; 80: 2012-2020.
7. 7. Lee A, Whyte MKB, Haslett C. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leuk Biol 1993; 54: 283-288.
8. 8. Grant SM, Heel RC. Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF). A review of its pharmacological properties and prospective role in the management of myelosuppression. Drugs 1992; 43: 516-560.
9. 9. Weisbart RH, Golde DW, Gasson JC. Biosynthetic human GM-CSF modulates the number and affinity of neutrophil f-Met-Leu-Phe receptors. J Immunol 1986; 137: 3584-3587.
10. 10. Weisbart RH, Golde DW, Clark SC et al. Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator. Nature 1985; 314: 361-363.
11. 11. Edwards SW, Watson F, MacLeod R, Davies JM. Receptor expression and oxidase activity in human neutrophils: regulation by granulocyte-macrophage colony-stimulating factor and dependence upon protein biosynthesis. Biosci Rep 1990; 10: 393-401.
12. 12. Kruh J. Effects of sodium butyrate, a new pharmacological agent on cells in culture. Mol Cell Biochem 1982; 42: 65-82.
13. 13. Quayle JA, Adams S, Bucknall RC et al. Cytokine expression by inflammatory neutrophils. FEMS Immunol Med Microbiol 1994; 8: 233-240.
14. 14. Peltz GA, Grundy HO, Lebo RV et al. Human FcγRIII: cloning, expression, and identification of the chromosomal locus of two Fc receptors for IgG. Proc Natn Acad Sci USA 1989; 86: 1013-1017.
15. 15. Ory PA, Clark MR, Kwoh EC, Clarkson SB and Goldstein IM: Sequences of complementary DNAs that encode the NA1 and NA2 forms of Fc receptor III on human neutrophils. J Clin Invest 1989; 84: 1688-1691.
16. 16. Quayle JA, Adams S, Bucknall RC et al. Interleukin-1 expression by neutrophils in rheumatoid arthritis. Ann Rheum Dis 1995; 54: 930-933.
17. 17. Dransfield I, Buckle A-M, Savill JS et al. Neutrophil apoptosis is associated with a reduction in CD16 (FcγRIII) expression. J Immunol 1994; 153: 1254-1263.
18. 18. Homburg CHE, de Haas M, von dem Borne AEGKr et al. Human neutrophils lose their surface FcγRIII and acquire annexin V binding sites during apoptosis in vitro. Blood 1995; 85: 532-540.
19. 19. Hughes V, Humphreys JM, Edwards SW. Protein synthesis is activated in "primed" neutrophils: a possible role in inflammation? Biosci Rep 1987; 7: 881-889.
20. 20. Edwards SW, Holden CS, Humphreys JM et al. Granulocyte-macrophage colony stimulating factor (GM-CSF) primes the respiratory burst and activates protein biosynthesis in human neutrophils. FEBS Lett 1989; 256: 62-66.
21. 21. Stringer RE, Hart CA, Edwards SW. Sodium butyrate delays neutrophil apoptosis. Role of protein biosynthesis in neutrophil survival. Br J Haematol 1996; 92: 169-175.
22. 22. Boffa LC, Vidali G, Mann RS et al. Suppression of histone deacetylation in vivo and in vitro by sodium butyrate. J Biol Chem 1978; 253: 3364-3366.
23. 23. Candido EPM, Reeves R and Davie JR: Sodium butyrate inhibits histone deacetylase in cultured cells. Cell 1978; 14: 105-113.
24. 24. Covault J, Perry M, Chalkey R. Effects of histone hyperacetylation and hypoacetylation on RNA synthesis in HTC cells. J Biol Chem 1982; 257: 13433-13440.
25. 25. Dresler SL. Stimulation of deoxyribonucleic acid excision repair in human fibroblasts pretreated with sodium butyrate. Biochemistry 1985; 24: 6861-6869.
26. 26. Sealy L, Chalkey R. The effect of sodium butyrate on histone modification. Cell 1978; 14: 115-121.
27. 27. Simpson RT. Structure of chromatin containing extensively acetylated H3 and H4. Cell 1978; 13: 691-699.
28. 28. Smerdon MJ, Lan SY, Calza RE et al. Sodium butyrate stimulates DNA repair in uv irradiated normal and xeroderma pigmentosum human fibroblasts. J Biol Chem 1982; 257: 13441-13447.
29. 29. Vidali G, Boffa LC, Bradbury EM, Allfrey VG. Butyrate suppression of histone deacetylation leads to accumulation of multiacetylated forms of histones H3 and H4 and increased DNaseI sensitivity of associated DNA sequences. Proc Nat Acad Sci USA 1978; 75: 2239-2243.
30. 30. Perrine SP, Faller DV. Butyrate-induced reactivation of the fetal globin genes: a molecular treatment for the β-hemoglobinopathies. Experientia 1993; 49: 133-137.
31. 31. Perrine SP, Ginder GD, Douglas VF et al. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the β-globin disorders. N Eng J Med 1993; 328: 81-86.
32. 32. Jost CR, Huizinga TWJ, de Goede R, Fransen JAM, Tetteroo PAT, Daha MR, Ginsel LA. Intracellular localization and de novo synthesis of FcRIII in human neutrophil granulocytes. Blood 1990; 75: 144-151.